aspartyl-glycyl-glutamyl-alanine

03/01/2000 - "Furthermore, the administration of anti-alpha2 integrin mAb or DGEA peptide in AZL5G-transplanted nude mice produced a significant reduction in the number of lymph node metastases. "

07/01/2011 - "The sarcophagine-conjugated DGEA peptide allows noninvasive imaging of tumor-associated α(2)β(1) expression, which may be a useful PET probe for evaluating the metastatic potential of prostate cancer."
01/01/2014 - "Nanodiamond-DGEA peptide conjugates for enhanced delivery of doxorubicin to prostate cancer."
12/01/2011 - "Recently, we reported that the DGEA peptide is a promising targeting ligand for near-infrared fluorescence and microPET imaging of integrin α(2)β(1) expression in prostate cancers. "
08/01/2011 - "The objective of this study was to design a novel imaging probe based on the Asp-Gly-Glu-Ala (DGEA) peptide for near-infrared-fluorescent (NIRF) imaging of α(2)β(1) integrin expression in prostate cancer. "
01/01/2014 - "NDs were conjugated with the Asp-Gly-Glu-Ala (DGEA) peptide to target α2β1 integrins over-expressed in prostate cancers during metastasis. "

07/01/2011 - "The sarcophagine-conjugated DGEA peptide allows noninvasive imaging of tumor-associated α(2)β(1) expression, which may be a useful PET probe for evaluating the metastatic potential of prostate cancer."
01/25/2019 - "Tumor targeting with DGEA peptide ligands: a new aromatic peptide amphiphile for imaging cancers."

01/01/2014 - "NDs were conjugated with the Asp-Gly-Glu-Ala (DGEA) peptide to target α2β1 integrins over-expressed in prostate cancers during metastasis. "

11/01/2004 - "Infection is inhibited by the alpha2beta1 ligand Asp-Gly-Glu-Ala (DGEA) and the alphaxbeta2 ligand Gly-Pro-Arg-Pro (GPRP), and virus-alpha2beta1 binding is increased by alpha2beta1 activation. "